Literature DB >> 3010869

Evidence for and partial characterization of three major and three minor chromatographic forms of human neutrophil myeloperoxidase.

K T Miyasaki, M E Wilson, E Cohen, P C Jones, R J Genco.   

Abstract

Myeloperoxidase (MPO) is an enzyme found in the azurophil granules of neutrophils. Cation-exchange chromatography on carboxymethyl-cellulose previously has been used to demonstrate the heterogeneity of the peroxidase enzymes isolated from human neutrophils. In this study, fast protein liquid chromatography (FPLC) was used to separate and purify three major (I, II, and III) and three minor (IIa, IIIa, IIIb) forms of MPO from isolated neutrophil granules. Purity was confirmed by polyacrylamide gel electrophoresis in the presence of cetyltrimethylammonium bromide (CETAB-PAGE), by crossed immunoelectrophoresis, and by spectral characteristics. All three major forms were indistinguishable by immunodiffusion against rabbit antiserum, scanning spectrophotometry, and amino acid composition. They differed in their elution from a cation-exchange resin, inhibition by 3-amino-1,2,4-triazole, migration rate in CETAB-PAGE, and subunit molecular weight. Subunit molecular weight was examined using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). All three major forms appeared to consist of heavy (H), intermediate (M), and light (L) peptides. The M peptide appeared to be derived from the H subunit. All L subunits exhibited a molecular weight of 14,500. The molecular weights for the H subunits varied, and were 60,000, 59,000, and 57,000 for MPO I, II, and III, respectively. The molecular weights for the M peptides were 44,100, 43,000, and 42,000 for MPO I, II, and III, respectively. The treatment of neutrophils, granules, and extracts with protease inhibitors and sodium azide did not block the appearance of three major forms of MPO. Thus, neither protease activity nor MPO autooxidation during extraction and purification procedures is responsible for the appearance of multiple chromatographic forms of MPO derived from human neutrophils.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010869     DOI: 10.1016/0003-9861(86)90332-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Purification of myeloperoxidase from equine polymorphonuclear leucocytes.

Authors:  M Mathy-Hartert; E Bourgeois; S Grülke; G Deby-Dupont; I Caudron; C Deby; M Lamy; D Serteyn
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

2.  Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.

Authors:  S W Edwards; V Hughes; J Barlow; R Bucknall
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

3.  Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans.

Authors:  K T Miyasaki; J J Zambon; C A Jones; M E Wilson
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

4.  In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins.

Authors:  K T Miyasaki; A L Bodeau; T Ganz; M E Selsted; R I Lehrer
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

5.  Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system.

Authors:  K T Miyasaki; M E Wilson; R J Genco
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

6.  In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity.

Authors:  K T Miyasaki; A L Bodeau
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

7.  Activity of polymorphonuclear leukocytes in the presence of sulfide.

Authors:  R Claesson; M Granlund-Edstedt; S Persson; J Carlsson
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

8.  Thyroid microsomal/thyroid peroxidase autoantibodies show discrete patterns of cross-reactivity to myeloperoxidase, lactoperoxidase and horseradish peroxidase.

Authors:  J P Banga; R W Tomlinson; N Doble; E Odell; A M McGregor
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

9.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.